Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor
暂无分享,去创建一个
A. Furiga | C. Roques | Aurelie Furiga | Barbora Lajoie | Salome El Hage | Genevieve Baziard | Christine Roques | B. Lajoie | S. El Hage | G. Baziard
[1] K. M. Lee,et al. Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[2] E. Pesci,et al. Dueling quorum sensing systems in Pseudomonas aeruginosa control the production of the Pseudomonas quinolone signal (PQS). , 2004, FEMS microbiology letters.
[3] E. Greenberg,et al. Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. Pritchard,et al. Quorum sensing and the population-dependent control of virulence. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[5] M. Bally,et al. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa , 1995, Journal of clinical microbiology.
[6] P. Seed,et al. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa , 1997, Journal of bacteriology.
[7] R. Hancock,et al. Pseudomonas aeruginosa: all roads lead to resistance. , 2011, Trends in microbiology.
[8] B. Iglewski,et al. Quorum-Sensing Genes in Pseudomonas aeruginosa Biofilms: Their Role and Expression Patterns , 2001, Applied and Environmental Microbiology.
[9] L. Leibovici,et al. Colistin: new lessons on an old antibiotic. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[10] Matthew R. Parsek,et al. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms , 2000, Nature.
[11] J. Costerton,et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. , 1998, Science.
[12] George M. Hilliard,et al. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. , 2002, Developmental cell.
[13] Jian Li,et al. Structure--activity relationships of polymyxin antibiotics. , 2010, Journal of medicinal chemistry.
[14] A. Oliver,et al. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[15] F. Baquero,et al. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients. , 2012, International journal of antimicrobial agents.
[16] T. B. Rasmussen,et al. Quorum-sensing inhibitors as anti-pathogenic drugs. , 2006, International journal of medical microbiology : IJMM.
[17] N. Høiby,et al. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model. , 2012, The Journal of antimicrobial chemotherapy.
[18] A. Furiga,et al. Growth inhibition of adherent Pseudomonas aeruginosa by an N-butanoyl-L-homoserine lactone analog. , 2010, Canadian journal of microbiology.
[19] Kathrine B. Christensen,et al. Identity and effects of quorum-sensing inhibitors produced by Penicillium species. , 2005, Microbiology.
[20] E. Greenberg,et al. Acyl-homoserine lactone quorum sensing in gram-negative bacteria: a signaling mechanism involved in associations with higher organisms. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[21] S. Kjelleberg,et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors , 2003, The EMBO journal.
[22] A. Brooks,et al. Microarray Analysis of Pseudomonas aeruginosa Quorum-Sensing Regulons: Effects of Growth Phase and Environment , 2003, Journal of bacteriology.
[23] L. Eberl,et al. Screening for Quorum-Sensing Inhibitors (QSI) by Use of a Novel Genetic System, the QSI Selector , 2005, Journal of bacteriology.
[24] G. Baziard-Mouysset,et al. Interactions between Biocide Cationic Agents and Bacterial Biofilms , 2002, Antimicrobial Agents and Chemotherapy.
[25] B. Iglewski,et al. Analysis of the Pseudomonas aeruginosa elastase (lasB) regulatory region , 1996, Journal of bacteriology.
[26] M. Hentzer,et al. Azithromycin Blocks Quorum Sensing and Alginate Polymer Formation and Increases the Sensitivity to Serum and Stationary-Growth-Phase Killing of Pseudomonas aeruginosa and Attenuates Chronic P. aeruginosa Lung Infection in Cftr−/− Mice , 2007, Antimicrobial Agents and Chemotherapy.
[27] C. van Delden,et al. Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. , 2003, The Journal of antimicrobial chemotherapy.
[28] A. Kirkham,et al. Pseudomonas aeruginosa Quorum-Sensing Systems May Control Virulence Factor Expression in the Lungs of Patients with Cystic Fibrosis , 2002, Infection and Immunity.
[29] S. Ichiyama,et al. Relationship between morphological changes and endotoxin release induced by carbapenems in Pseudomonas aeruginosa. , 1999, Journal of medical microbiology.
[30] S. Kjelleberg,et al. Impact of Pseudomonas aeruginosa quorum sensing on biofilm persistence in an in vivo intraperitoneal foreign-body infection model. , 2007, Microbiology.
[31] J. Collins,et al. How antibiotics kill bacteria: from targets to networks , 2010, Nature Reviews Microbiology.
[32] T. B. Rasmussen,et al. Rational design and synthesis of new quorum-sensing inhibitors derived from acylated homoserine lactones and natural products from garlic. , 2005, Organic & biomolecular chemistry.
[33] D. Pritchard,et al. Synthetic analogues of the bacterial signal (quorum sensing) molecule N-(3-oxododecanoyl)-L-homoserine lactone as immune modulators. , 2003, Journal of medicinal chemistry.
[34] L. Lutz,et al. Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm , 2012, BMC Microbiology.
[35] H. Vogel,et al. In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangement. , 1991, The Journal of infectious diseases.
[36] Richard C Boucher,et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.
[37] B. Iglewski,et al. Azithromycin Retards Pseudomonas aeruginosa Biofilm Formation , 2004, Journal of Clinical Microbiology.
[38] B. Iglewski,et al. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes , 1997, Journal of bacteriology.
[39] E. Greenberg,et al. A network of networks: quorum-sensing gene regulation in Pseudomonas aeruginosa. , 2006, International journal of medical microbiology : IJMM.
[40] Daniel Yordanov,et al. Pseudomonas aeruginosa - a phenomenon of bacterial resistance. , 2009, Journal of medical microbiology.
[41] G. Pier,et al. Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[42] T. Coenye,et al. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model , 2012 .
[43] R. Hancock,et al. Interactions of Bacterial Cationic Peptide Antibiotics with Outer and Cytoplasmic Membranes ofPseudomonas aeruginosa , 2000, Antimicrobial Agents and Chemotherapy.
[44] E. Pesci,et al. Regulation of Pseudomonas Quinolone Signal Synthesis in Pseudomonas aeruginosa , 2005, Journal of bacteriology.
[45] B. Iglewski,et al. Cell-to-cell signaling and Pseudomonas aeruginosa infections. , 1998, Emerging infectious diseases.
[46] A. Prince,et al. Pseudomonas aeruginosa Cell-to-Cell Signaling Is Required for Virulence in a Model of Acute Pulmonary Infection , 2000, Infection and Immunity.
[47] R. Hancock,et al. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria , 2007, Expert review of anti-infective therapy.
[48] C. van Delden,et al. Detection of Pseudomonas aeruginosa cell-to-cell signals in lung tissue of cystic fibrosis patients. , 2002, Microbial pathogenesis.
[49] M. Elkins,et al. Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolates Derived from Patients with Cystic Fibrosis under Aerobic, Anaerobic, and Biofilm Conditions , 2005, Journal of Clinical Microbiology.
[50] K. Miller,et al. Elastase of Pseudomonas aeruginosa: Inactivation of Complement Components and Complement-Derived Chemotactic and Phagocytic Factors , 1974, Infection and immunity.
[51] Alfred Pingoud,et al. Real‐Time Polymerase Chain Reaction , 2003, Chembiochem : a European journal of chemical biology.
[52] R. Duval,et al. Nanoscale effects of antibiotics on P. aeruginosa. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[53] J. Rolain,et al. Colistin: an update on the antibiotic of the 21st century , 2012, Expert review of anti-infective therapy.
[54] Russell M. Taylor,et al. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms , 2006, Proceedings of the National Academy of Sciences.
[55] M. Rosenthal,et al. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial , 2002, The Lancet.
[56] Miguel Cámara,et al. Direct detection of N-acylhomoserine lactones in cystic fibrosis sputum. , 2002, FEMS microbiology letters.
[57] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[58] G. O’Toole,et al. Rhamnolipid Surfactant Production Affects Biofilm Architecture in Pseudomonas aeruginosa PAO1 , 2003, Journal of bacteriology.
[59] M. Son,et al. In Vivo Evidence of Pseudomonas aeruginosa Nutrient Acquisition and Pathogenesis in the Lungs of Cystic Fibrosis Patients , 2007, Infection and Immunity.
[60] N. Høiby,et al. Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem on Mucoid and Nonmucoid Pseudomonas aeruginosa Biofilms , 2011, Antimicrobial Agents and Chemotherapy.
[61] S. Chhibber,et al. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections. , 2015, International journal of antimicrobial agents.